HomeBUSINESS
BUSINESS

JT Wins Japan Commercialization Rights for Calcifediol Extended-Release Capsules
(Oct.16.2017)

Japan Tobacco said on October 12 that it has entered into a license agreement with EirGen Pharma for exclusive rights to develop and commercialize the Irish firm’s calcifediol extended-release capsules for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease in Japan ...
(LOG IN FOR FULL STORY)

News Calendar